Physician profile
Sufia Khan
NPI 1508271800
$2,052.38
in general payments reported to CMS, 2019-2025
33 companies · $596 in 2025
The $596 reported for 2025 was more than what 77% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $142 · 2021: $153 · 2022: $41.68 · 2023: $440 · 2024: $680 · 2025: $596.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,716.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,715.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $242.75 | 2023-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $230.85 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $168.90 | 2020-2025 | Repatha, Otezla, Evenity |
| Novartis Pharmaceuticals Corporation | $138.98 | 2023-2025 | |
| Pfizer INC. | $106.74 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.70 | 2023-2025 | Jardiance |
| Dexcom, INC. | $99.05 | 2023-2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $88.80 | 2020-2025 | Freestyle Libre 3, Jot Dx |
| Abbvie INC. | $87.47 | 2021-2024 | |
| Edwards Lifesciences Corporation | $79.25 | 2024-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Astrazeneca Pharmaceuticals LP | $55.14 | 2020-2025 | Breztri, Farxiga |
| Exact Sciences Corporation | $52.15 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Eisai INC. | $51.66 | 2020 | |
| Gilead Sciences, INC. | $50.42 | 2023-2025 | Epclusa |
| Lilly USA, LLC | $47.02 | 2025 | Mounjaro, Jardiance |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Renalytix Ai, INC. | $38.46 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Kowa Pharmaceuticals America, INC. | $37.95 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $35.64 | 2021 | |
| Sanofi-Aventis U.S. LLC | $33.51 | 2023 | |
| Inspire Medical Systems, INC. | $32.86 | 2024-2025 | Inspire |
| Tactile Systems Technology INC | $31.28 | 2025 | Nimbl, Flexitouch Plus |
| Astellas Pharma US INC | $26.31 | 2024 | Veozah |
| Boston Scientific Corporation | $26.28 | 2022 | |
| Medtronic, INC. | $25.07 | 2024 | Venaseal |
| Sanofi Pasteur INC. | $24.83 | 2023 | |
| Hologic Sales and Service, LLC | $24.23 | 2024 | Aptima |
| Axonics, INC. | $20.21 | 2023 | Axonics |
| Nevro Corp. | $20.11 | 2024 | Senza |
| Paratek Pharmaceuticals, INC. | $18.36 | 2025 | Nuzyra |
| Merck Sharp & Dohme LLC | $15.73 | 2024 | Capvaxive, Gardasil, Gardasil 9 |
| Idorsia Pharmaceuticals US INC | $14.67 | 2024 | Quviviq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.32 | 2020 | |
| Acerus Pharmaceuticals Corporation | $12.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sufia Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.